Advances in immunotherapy for pancreatic cancer: 2013.

Published online

Journal Article

Pancreatic cancer is one of the more difficult malignancies to treat, and there is a great need for less toxic, effective regimens. Immunotherapy has shown potential in the treatment of pancreatic cancer, and at ASCO 2013 there were several progressive advances in its clinical application. Abstracts #3067, #3049, #3007, #4040, #LBA4004, and #3090 will be discussed. New developments in the field of immunotherapy are promising novel treatments for pancreatic neoplasms with tolerable side effect profiles.

Full Text

Duke Authors

Cited Authors

  • DeVito, NC; Saif, MW

Published Date

  • July 10, 2013

Published In

Volume / Issue

  • 14 / 4

Start / End Page

  • 347 - 353

PubMed ID

  • 23846925

Pubmed Central ID

  • 23846925

Electronic International Standard Serial Number (EISSN)

  • 1590-8577

Digital Object Identifier (DOI)

  • 10.6092/1590-8577/1646

Language

  • eng

Conference Location

  • Italy